Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report

Nicholas Berg; Onyedika Ilonze; Vatsal Bajpai; Maya Guglin; Roopa Rao

doi:10.1016/j.transproceed.2021.03.013

Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report

Transplant Proc. 2021 May;53(4):1224-1226. doi: 10.1016/j.transproceed.2021.03.013. Epub 2021 Mar 19.

Authors

Nicholas Berg¹, Onyedika Ilonze², Vatsal Bajpai², Maya Guglin², Roopa Rao²

Affiliations

¹ Indiana University School of Medicine Internal Medicine Residency, Indianapolis, Indiana. Electronic address: njberg@iu.edu.
² Division of Cardiology, Krannert Institute of Cardiology at Indiana University School of Medicine, Indianapolis, Indiana.

Abstract

The cardiac effects of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include myocarditis, takotsubo cardiomyopathy, pericardial effusion, and cardioembolic events in the general population. The effects of SARS-CoV-2 in heart transplant patients are unclear. We describe a case of myocarditis in the transplanted heart that responded to methylprednisolone.

Publication types

Case Reports

MeSH terms

Aged
COVID-19 / complications
COVID-19 / diagnosis*
COVID-19 / virology
Glucocorticoids / pharmacology
Glucocorticoids / therapeutic use
Heart Failure / complications
Heart Failure / therapy
Heart Transplantation*
Humans
Male
Methylprednisolone / pharmacology
Methylprednisolone / therapeutic use
Myocarditis / diagnosis*
Myocarditis / drug therapy
SARS-CoV-2 / isolation & purification
Transplantation, Homologous
Ventricular Function, Left / drug effects

Substances

Glucocorticoids
Methylprednisolone